Improving the screening of risk factors in diabetic retinopathy

References

• Kocur I, Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol. 2002 Jul;86(7):716–722.
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Gupta B, Gulliford MC, et al. Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK). PloS one. 2012;7(6):e39608.
   PubMedGoogle Scholar
• Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open. 2014Feb12;4(2):e004015.
   PubMed Web of Science ®Google Scholar
• Lawrenson JG, Bourmpaki E, Bunce C, et al. Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort. Diabet Med. 2021 Apr;38(4):e14425.
   PubMedGoogle Scholar
• Scanlon PH. The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges. Acta Diabetol. 2021 Apr;58(4):521–530.
   PubMedGoogle Scholar
• Open Athens. 2019. [Accessed 2022 January 10]. Available from: https://www.openathens.net/
   Google Scholar
• Royal Society of Medicine. 2019. [Accessed 2022 January 10]. Available from: https://www.rsm.ac.uk/the-library/
   Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984 Apr;102(4):520–526.
   PubMedGoogle Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984 Apr;102(4):527–532.
   PubMed Web of Science ®Google Scholar
• Scanlon PH, Nevill CR, Stratton IM, et al. Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire. Acta Ophthalmol. 2021 Jun 28;100(2):e560–e570.
   PubMedGoogle Scholar
• Broe R, Rasmussen ML, Frydkjaer-Olsen U, et al. The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: the Danish cohort of pediatric diabetes 1987 (DCPD1987). Acta Diabetol. 2014 Jun;51(3):413–420.
   PubMedGoogle Scholar
• Wong TY, Mwamburi M, Klein R, et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009 Dec;32(12):2307–2313.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995 Jan;102(1):7–16.
   PubMed Web of Science ®Google Scholar
• Kiire CA, Horak K, Lee KE, et al. The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: a longitudinal cohort study. PloS one. 2017;12(3):e0174979.
   PubMedGoogle Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991 May;98(5 Suppl):786–806.
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991 May;98(5 Suppl):823–833.
   PubMed Web of Science ®Google Scholar
• Aldington SJ, Stratton IM, Matthews DR, et al. Relationship of retinal microaneurysm count to progression of retinopathy over 3 and 6 years in non-insulin dependent diabetes. Diabetic Med. 1995;12(Suppl 1):3.
   Google Scholar
• Klein R, Meuer SM, Moss SE, et al. Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol. 1995 Nov;113(11):1386–1391.
   PubMedGoogle Scholar
• Sjolie AK, Klein R, Porta M, et al. Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabet Med. 2011 Mar;28(3):345–351.
   PubMed Web of Science ®Google Scholar
• Scanlon PH, Stratton IM, Histed M, et al. The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010. Acta Ophthalmol. 2013 Aug;91(5):e335–9.
   PubMedGoogle Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30; 329(14):977–986.
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1994 Aug;125(2):177–188.
   PubMedGoogle Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131): 837–853.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998 Sep 12;352(9131): 854–865.
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009 Mar;116(3):497–503.
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008 Nov;115(11):1859–1868.
   PubMed Web of Science ®Google Scholar
• Klein BE. Progression of retinopathy in persons with type 2 diabetes: new data, same conclusions? Pol Arch Med Wewn. 2010 Oct;120(10):413–416.
   PubMedGoogle Scholar
• DCCT. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998 Jul;116(7):874–886.
   PubMedGoogle Scholar
• Henricsson M, Berntorp K, Fernlund P, et al. Progression of retinopathy in insulin-treated type 2 diabetic patients. Diabetes Care. 2002 Feb;25(2):381–385.
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care. 2000 Aug;23(8):1084–1091.
   PubMedGoogle Scholar
• Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. Diabetes Care. 1995 May;18(5):631–637. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study
   PubMed Web of Science ®Google Scholar
• Phelps RL, Sakol P, Metzger BE, et al. Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol. 1986 Dec;104(12):1806–1810.
   PubMedGoogle Scholar
• Kim YJ, Shin S, Han DJ, et al. Long-term effects of pancreas transplantation on diabetic retinopathy and incidence and predictive risk factors for early worsening. Transplantation. 2018 Jan;102(1):e30–e38.
   PubMedGoogle Scholar
• Merlotti C, Ceriani V, Morabito A, et al. Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies. Obes Rev. 2017 Mar;18(3):309–316.
   PubMedGoogle Scholar
• Feldman-Billard S, Larger É, Massin P. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes Metab. 2018 Feb;44(1):4–14.
   PubMed Web of Science ®Google Scholar
• Joner G, Brinchmann-Hansen O, Torres CG, et al. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992 Nov;35(11):1049–1054.
   PubMedGoogle Scholar
• Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol. 2004 Nov;122(11):1631–1640.
   PubMedGoogle Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Bmj. 1998 Sep 12;317(7160): 703–713.
   PubMed Web of Science ®Google Scholar
• Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010 Jul 15;363(3):233–244.
   PubMed Web of Science ®Google Scholar
• Patel A, Group AC, MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007 Sep 8;370(9590):829–840.
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564.
   PubMed Web of Science ®Google Scholar
• Scanlon PH, Stratton IM, Bachmann MO, et al. Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age. Diabet Med. 2016 Dec;33(12):1655–1658.
   PubMedGoogle Scholar
• Leske MC, Wu SY, Hennis A, et al. Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology. 2003 May;110(5):941–947.
   PubMedGoogle Scholar
• Simmons D, Clover G, Hope C. Ethnic differences in diabetic retinopathy. Diabet Med. 2007 Oct;24(10):1093–1098.
   PubMedGoogle Scholar
• Raymond NT, Varadhan L, Reynold DR, et al. Higher prevalence of retinopathy in diabetic patients of south Asian ethnicity compared to white Europeans in the community: a cross sectional study. Diabetes Care. 2009 Dec 15;32(3):410–415.
   PubMed Web of Science ®Google Scholar
• Thomas RL, Distiller L, Luzio SD, et al. Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa. Diabetes Care. 2013;36(2):336–341.
   PubMedGoogle Scholar
• Chew EY, Klein ML, Ferris FL 3rd, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996 Sep;114(9):1079–1084.
   PubMedGoogle Scholar
• Modjtahedi BS, Bose N, Papakostas TD, et al. Lipids and diabetic retinopathy. Semin Ophthalmol. 2016;31(1–2):10–18.
   PubMed Web of Science ®Google Scholar
• Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci. 2004 Mar;45(3):910–918.
   PubMed Web of Science ®Google Scholar
• Muhlhauser I, Bender R, Bott U, et al. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med. 1996 Jun;13(6):536–543.
   PubMedGoogle Scholar
• Karamanos B, Porta M, Songini M, et al. Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia. 2000 Mar;43(3):348–355.
   PubMedGoogle Scholar
• Gaedt Thorlund M, Borg Madsen M, Green A, et al. Is smoking a risk factor for proliferative diabetic retinopathy in type 1 diabetes? Ophthalmol J Int D’ophtalmologie Int J Ophthalmol Zeitschrift Fur Augenheilkunde. 2013;230(1):50–54.
   Google Scholar
• Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001 Feb;44(2):156–163.
   PubMed Web of Science ®Google Scholar
• Hietala K, Harjutsalo V, Forsblom C, et al. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care. 2010 Jun;33(6):1315–1319.
   PubMedGoogle Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994 Sep;112(9):1217–1228.
   PubMedGoogle Scholar
• Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol. 2014 Jan;132(1):96–107.
   PubMed Web of Science ®Google Scholar
• Hietala K, Forsblom C, Summanen P, et al. Heritability of proliferative diabetic retinopathy. Diabetes. 2008 Aug;57(8):2176–2180.
   PubMedGoogle Scholar
• Jie X, Zhengxuan J, Liang Z, et al. Analysis of genetic susceptibility to proliferative diabetic retinopathy in Han patients with type 2 diabetes from Southern China by whole exome sequencing and SnaPshot. Chin J Exper Ophthalmol. 2018;36(1): 31–40
   Google Scholar
• Leslie RD, Pyke DA. Diabetic retinopathy in identical twins. Diabetes. 1982 Jan;31(1):19–21.
   PubMed Web of Science ®Google Scholar
• Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes. 2007 Apr;56(4):1160–1166.
   PubMedGoogle Scholar
• Rema M, Saravanan G, Deepa R, et al. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabet Med. 2002 Nov;19(11):910–916.
   PubMedGoogle Scholar
• Zhang X, Gao Y, Zhou Z, et al. Familial clustering of diabetic retinopathy in Chongqing, China, type 2 diabetic patients. Eur J Ophthalmol. 2010;20(5):911–918.
   PubMedGoogle Scholar
• Hallman DM, Huber JC Jr., Gonzalez VH, et al. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005 May;28(5):1163–1168.
   PubMedGoogle Scholar
• Arar NH, Freedman BI, Adler SG, et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3839–3845.
   PubMed Web of Science ®Google Scholar
• Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990 Jan;13(1):34–40.
   PubMed Web of Science ®Google Scholar
• Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol. 1992 Apr;166(4):1214–1218.
   PubMed Web of Science ®Google Scholar
• Lauszus F, Klebe JG, Bek T. Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand. 2000 May;79(5):367–370.
   PubMedGoogle Scholar
• Dibble CM, Kochenour NK, Worley RJ, et al. Effect of pregnancy on diabetic retinopathy. Obstet Gynecol. 1982 Jun;59(6):699–704.
   PubMed Web of Science ®Google Scholar
• Temple RC, Aldridge VA, Sampson MJ, et al. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet Med. 2001 Jul;18(7):573–577.
   PubMed Web of Science ®Google Scholar
• Wolf S, Arend O, Toonen H. Measurement of retinal micro- and macrocirculation in patients with diabetes mellitus with scanning laser ophthalmoscopy. Clin Vis Sci. 1992;7:462–469.
   Google Scholar
• Bulum T, Prkacin I, Duvnjak L. High prevalence of retinopathy in patients with type 2 diabetes and normal renal function. Nephrol Dialysis Transplantation. 2017;32(suppl_3):iii278–iii278.
   Google Scholar
• Colhoun H, Lee E, Bennett P, et al. Risk factors for renal failure: the WHO mulinational study of vascular disease in diabetes. Diabetologia. 2001;Supplement 2:S46–53.
   Google Scholar
• Grunwald JE, Alexander J, Ying G-S. Retinopathy and chronic kidney disease in the chronic renal insufficiency cohort (CRIC) study. Arch Ophthalmol. 2012;130(9):1136.
   PubMedGoogle Scholar
• Grunwald JE, Pistilli M, Ying GS, et al. Association between progression of retinopathy and concurrent progression of kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. JAMA Ophthalmol. 2019 Jul 1;137(7):767–774.
   PubMed Web of Science ®Google Scholar
• He F, Xia X, Wu XF, et al. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia. 2013;56(3):457–466.
   PubMed Web of Science ®Google Scholar
• Moriya T, Tanaka S, Kawasaki R, et al. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study. Diabetes Care. 2013 Sep;36(9):2803–2809.
   PubMedGoogle Scholar
• Kaewput W, Thongprayoon C, Rangsin R, et al. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: a multicenter nationwide cross-sectional study. World J Nephrol. 2019 Feb 21;8(2):33–43.
   PubMedGoogle Scholar
• Zhuang X, Cao D, Yang D, et al. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study. BMJ open. 2019;9(9):e031194–e031194.
   PubMedGoogle Scholar
• Tong PC, Kong AP, So WY, et al. Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus. Diabet Med. 2007 Jul;24(7):741–746.
   PubMedGoogle Scholar
• Pugliese G, Solini A, Zoppini G, et al. High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Res Clin Pract. 2012;98(2):329–337.
   PubMedGoogle Scholar
• Wong TY, Shankar A, Klein R, et al. Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes. 2004 Jan;53(1):179–184.
   PubMedGoogle Scholar
• Benitez-Aguirre P, Craig ME, Sasongko MB, et al. Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence. Diabetes Care. 2011 Jul;34(7):1622–1627.
   PubMedGoogle Scholar
• Benitez-Aguirre PZ, Sasongko MB, Craig ME, et al. Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care. 2012;35(3):599–604.
   PubMed Web of Science ®Google Scholar
• Zoega GM, Gunnarsdottir T, Bjornsdottir S, et al. Screening compliance and visual outcome in diabetes. Acta Ophthalmologica Scandinavica. 2005 Dec;83(6):687–690.
   PubMedGoogle Scholar
• Gray R, Blades C, Jobson C. Screening clinic non-attendance and the risk of sight threatening retinopathy. Eur J Ophthalmol. 2009;19(3):510.
   Google Scholar
• Forster AS, Forbes A, Dodhia H, et al. Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study. Diabetologia. 2013 Oct;56(10):2187–2193.
   PubMedGoogle Scholar
• Scanlon PH, Aldington SJ, Stratton IM. Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy. Diabet Med. 2014 Apr;31(4):439–442.
   PubMed Web of Science ®Google Scholar
• Sachdeva A, Stratton IM, Unwin J, et al. Diabetic retinopathy screening: study to determine risk factors for non-attendance. Diabetes Prim Care. 2012;14(5): 308–316
   Google Scholar
• Scanlon PH, Stratton IM, Leese GP, et al. Screening attendance, age group and diabetic retinopathy level at first screen. Diabet Med. 2016 Jul;33(7):904–911.
   PubMedGoogle Scholar
• Kashim RM, Newton P, Ojo O. Diabetic retinopathy screening: a systematic review on patients’ non-attendance. Int J Environ Res Public Health. 2018;15(1):157.
   Web of Science ®Google Scholar
• Kelly SR, Loiselle AR, Pandey R, et al. Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2). Acta Diabetol. 2021 May;58(5):643–650.
   PubMedGoogle Scholar
• West SD, Groves DC, Lipinski HJ, et al. The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabet Med. 2010 Apr;27(4):423–430.
   PubMedGoogle Scholar
• Banerjee D, Leong WB, Arora T, et al. The potential association between obstructive sleep apnea and diabetic retinopathy in severe obesity-the role of hypoxemia. PloS one. 2013;8(11):e79521.
   PubMedGoogle Scholar
• Zhang R, Guo X, Guo L, et al. Prevalence and associated factors of obstructive sleep apnea in hospitalized patients with type 2 diabetes in Beijing, China 2. J Diabetes. 2015 Jan;7(1):16–23.
   PubMedGoogle Scholar
• Storgaard H, Mortensen B, Almdal T, et al. At least one in three people with Type 2 diabetes mellitus referred to a diabetes centre has symptomatic obstructive sleep apnoea. Diabet Med. 2014 Nov;31(11):1460–1467.
   PubMedGoogle Scholar
• Manin G, Pons A, Baltzinger P, et al. Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications. Diabet Med. 2015 Jan;32(1):90–96.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang F, Liu Y, et al. Relationship of obstructive sleep apnoea with diabetic retinopathy: a meta-analysis. Biomed Res Int. 2017;2017:5.
   Google Scholar
• Feher M, Hinton W, Munro N, et al. Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis. Diabet Med. 2019 Oct;36(10):1304–1311.
   PubMedGoogle Scholar
• Ranil P, Raman R, Rachepalli S, et al. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India. 2010;58:91–98.
   PubMedGoogle Scholar
• Chung JO, Park SY, Chung DJ, et al. Relationship between anemia, serum bilirubin concentrations, and diabetic retinopathy in individuals with type 2 diabetes. Medicine (Baltimore). 2019;98(43):e17693. In eng.
   PubMedGoogle Scholar
• Li Y, Yu Y, VanderBeek BL. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy. Eye (Lond). 2020;34(5):934–941.
   PubMedGoogle Scholar
• Traveset A, Rubinat E, Ortega E, et al. Lower hemoglobin concentration is associated with retinal ischemia and the severity of diabetic retinopathy in type 2 diabetes. J Diabetes Res. 2016;2016:3674946.
   PubMedGoogle Scholar
• Sepulveda FJ, Perez P, Medinilla MG, et al. Anemia as a factor related to the progression of proliferative diabetic retinopathy after photocoagulation. J Diabetes Complications. 2012;26(5):454–457.
   PubMedGoogle Scholar
• Scanlon PH, Aldington SJ, Leal J, et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess. 2015 Sep;19(74):1–116.
   PubMedGoogle Scholar
• NSC. UK NSC screening recommendation on changing the screening interval from every year to every 2 years for people at low risk of sight loss 2016. [Accessed 2022 January 10]. Available from: https://view-health-screening-recommendations.service.gov.uk/diabetic-retinopathy/
   Google Scholar
• Stratton IM, Aldington SJ, Taylor DJ, et al. A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care. 2013 Mar;36(3):580–585.
   PubMedGoogle Scholar
• Aspelund T, Thornorisdottir O, Olafsdottir E, et al. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia. 2011 Oct;54(10):2525–2532.
   PubMed Web of Science ®Google Scholar
• Lund SH, Aspelund T, Kirby P, et al. Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs. Br J Ophthalmol. 2016 May;100(5):683–687.
   PubMedGoogle Scholar
• Smith JJ, Wright DM, Stratton IM, et al. Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort. Br J Ophthalmol. 2021 Apr 26. DOI:https://doi.org/10.1136/bjophthalmol-2020-318570.
   Google Scholar
• van der Heijden AA, Nijpels G, Badloe F, et al. Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting. Diabetologia. 2020 Jun;63(6):1110–1119.
   PubMedGoogle Scholar
• PHE. Diabetic eye screening standards valid for data collected from 1 April 2019. [Accessed 2022 January 10]. Available from: https://www.gov.uk/government/publications/diabetic-eye-screening-programme-standards/diabetic-eye-screening-standards-valid-for-data-collected-from-1-april-2019
   Google Scholar
• Philip SL, Black N, Sharp M, et al. Impact of introducing automated grading into the Scottish national diabetic retinopathy screening programme. Manchester: Diabetic Medicine; 2017. p. 457.
   Google Scholar